Sen. Brownback Wants FDA To Aggressively Coordinate Drug Development For Neglected/Rare Diseases
This article was originally published in The Pink Sheet Daily
Executive Summary
The Kansas Republican suggests the agency could get all parties, including investors, into the action to push therapies past the approval goal posts.